AR and neoplasm: In the Kaplan-Meier analysis in the monotherapy population (n = 1753), BCFI was better for those assigned to letrozole than tamoxifen, regardless of tumor AR expression (AR+ p = 0.02 from log-rank test; AR− p = 0.04) (Fig. 3).